Skip to product information
1 of 7

Proven Medical Testing

COVID-19/Flu A&B Antigen Test Pro - (25 pack)

COVID-19/Flu A&B Antigen Test Pro - (25 pack)

Regular price $125.00 USD
Regular price Sale price $125.00 USD
Sale Temporarily Out of Stock
Traceable Sourcing
Free Shipping Over $300
Secure Checkout
Need bulk pricing? Request a quote

The COVID-19/Flu A&B Antigen Test Pro is a lateral flow immunochromatographic assay for the qualitative detection and differentiation of influenza A and influenza B nucleoprotein antigens and SARS-CoV-2 nucleocapsid antigen from anterior nasal swab samples, in individuals with signs and symptoms of respiratory tract infection.

  1. Three results from a single anterior nasal swab: COVID-19, Influenza A and Influenza B
  2. Results read between 15 and 20 minutes
  3. Procedural control line in both result windows confirms a valid run
  4. 25 sealed cassettes per box with pre-filled extraction tubes, tube tips and tube holders

For in vitro diagnostic use. Intended for use in individuals aged 2 years and older. Do not use the test if the patient has had symptoms for more than 5 days, or no symptoms at all. Sold to healthcare professionals only. Negative results are presumptive and should be confirmed with an FDA-cleared molecular assay when determined to be appropriate by a healthcare provider. Positive results do not rule out co-infection with other respiratory pathogens.

VIEW INSTRUCTIONS FOR USE (PDF)

Volume pricing: 10% off when you buy 10 or more boxes and 20% off at 50 or more boxes, applied automatically at checkout. For 200 or more boxes, contact us for a quote.

Specifications

ManufacturerProven Medical Testing
Sold byBox of 25 tests
Sample typeAnterior nasal swab (direct)
Time to results15 minutes (read between 15 and 20 minutes)
Storage temperature36–86°F (2–30°C), out of direct sunlight
SterilitySterile nasal swabs (25); other components supplied non-sterile
DisposableYes, single-use cassette, swab and extraction tube
Catalog number (REF)GCFC-5258Kcu
CPT code87812 (QW modifier for CLIA-waived sites)
CLIA complexityWaived
FDA statusFDA De Novo authorized, Class II

Kit contents

  • 25 sealed test cassettes
  • 25 sterile nasal swabs
  • 25 pre-filled extraction tubes
  • 25 extraction tube tips
  • 2 tube holders
  • 1 Instructions for Use (IFU)
  • 1 Quick Reference Instructions (QRI)

Clinical performance

  • SARS-CoV-2: PPA/Sensitivity 92.0% (69/75), 95% CI 83.6–96.3%; NPA/Specificity 99.0% (1012/1022), 95% CI 98.2–99.5%
  • Influenza A: PPA/Sensitivity 92.5% (49/53), 95% CI 82.1–97.0%; NPA/Specificity 99.9% (1068/1069), 95% CI 99.5–100.0%
  • Influenza B: PPA/Sensitivity 90.5% (38/42), 95% CI 77.9–96.2%; NPA/Specificity 99.9% (1079/1080), 95% CI 99.5–100.0%

Prospective study at ten U.S. sites versus FDA-cleared RT-PCR, anterior nasal swabs, symptom onset 0–5 days (1,122 evaluable subjects). Instructions for Use rev. 2026-05-07, doc B25374-01.

View full details